Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.
about
Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Evaluating the impact of the A ...... th severe ADAMTS13 deficiency.
@en
type
label
Evaluating the impact of the A ...... th severe ADAMTS13 deficiency.
@en
prefLabel
Evaluating the impact of the A ...... th severe ADAMTS13 deficiency.
@en
P2860
P356
P1433
P1476
Evaluating the impact of the A ...... th severe ADAMTS13 deficiency.
@en
P2093
P2860
P304
P356
10.1111/VOX.12511
P577
2017-03-31T00:00:00Z